stockrowAlvotech (ALVO) vs BioCryst Pharmaceuticals, Inc. (BCRX)
- Alvotech ALVO 4.81 +5.71%
- BioCryst Pharmaceuticals, Inc. BCRX 7.67 +0.52%
Alvotech and BioCryst Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech and BioCryst Pharmaceuticals, Inc. are of similar size ($2.0B and $1.8B). Alvotech grew revenue faster over the last twelve months: 364.3% against 60.3%. BioCryst Pharmaceuticals, Inc. has the higher net margin (−37.4% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, BioCryst Pharmaceuticals, Inc. leads on 12 and Alvotech on 3.
Valuation
Profitability
| Metric | ALVO | BCRX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 97.89% | 53.51% |
| Operating margin | (42.43%) | (30.10%) | 0.00% |
| Net margin | (101.05%) | (37.41%) | (2.45%) |
| Free cash flow margin | 0.00% | 38.11% | 0.00% |
| Return on equity | 0.00% | 91.60% | (0.80%) |
| Return on assets | 0.00% | (69.33%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack